Allosteric inhibitors of hepatitis C polymerase: Discovery of potent and orally bioavailable carbon-linked dihydropyrones

被引：36

作者：

Li, Hui ^{[1
]}

Linton, Angelica ^{[1
]}

Tatlock, John ^{[1
]}

Gonzalez, Javier ^{[1
]}

Borchardt, Allen ^{[1
]}

Abreo, Mel ^{[1
]}

Jewell, Tanya ^{[1
]}

Patel, Leena ^{[1
]}

Drowns, Matthew ^{[1
]}

Ludlum, Sarah ^{[1
]}

Goble, Mike ^{[1
]}

Yang, Michele ^{[1
]}

Blazel, Julie ^{[1
]}

Rahavendran, Ravi ^{[1
]}

Skor, Heather ^{[1
]}

Shi, Stephanie ^{[1
]}

Lewis, Cristina ^{[1
]}

Fuhrman, Shella ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, La Jolla Labs, San Diego, CA 92121 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2007年 / 50卷 / 17期

关键词：

D O I：

10.1021/jm0704447

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The discovery and optimization of a novel class of carbon-linked dihydropyrones as allosteric HCV NS5B polymerase inhibitors are presented. Replacement of the sulfur linker atom with carbon reduced compound acidity and greatly increased cell permeation. Further structure-activity relationship (SAR) studies led to the identification of compounds, exemplified by 23 and 24, with significantly improved antiviral activities in the cell-based replicon assay and favorable pharmacokinetic profiles.

引用

页码：3969 / 3972

页数：4

共 50 条

[1] Discovery of Potent, Orally Bioavailable Inhibitors of Human Cytomegalovirus
Fader, Lee
Brault, Martine
Desjardins, Jessica
Dansereau, Nathalie
Lamorte, Louie
Tremblay, Sonia
Bilodeau, Francois
Bordeleau, Josee
Duplessis, Martin
Gorys, Vida
Gillard, James
Gleason, James L.
James, Clint
Joly, Marc-Andre
Kuhn, Cyrille
Llinas-Brunet, Montse
Luo, Laibin
Morency, Louis
Morin, Sebastien
Parisien, Mathieu
Poirier, Maude
Thibeault, Carl
Thao Trinh
Sturino, Claudio
Srivastava, Sanjay
Yoakim, Christiane
Franti, Michael
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (05): : 525 - 530
[2] Discovery of potent and orally bioavailable macrocyclic FXIa inhibitors
Yang, Wu
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
[3] Discovery of 5-Azaquinoxaline Derivatives as Potent and Orally Bioavailable Allosteric SHP2 Inhibitors
Elsayed, Mohamed S. A.
Blake, James F.
Boys, Mark L.
Brown, Eric
Chapsal, Bruno D.
Chicarelli, Mark J.
Cook, Adam W.
Fell, Jay B.
Fischer, John P.
Hanson, Lauren
Lemieux, Christine
Martinson, Matthew C.
McCown, Joseph
McNulty, Oren T.
Mejia, Macedonio J.
Neitzel, Nickolas A.
Otten, Jennifer N.
Rodriguez, Martha E.
Wilcox, Daniel
Wong, Christina E.
Zhou, Yeyun
Hinklin, Ronald J.
ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (12): : 1673 - 1681
[4] Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors
Li, Guo
Meanwell, Nicholas A.
Krystal, Mark R.
Langley, David R.
Naidu, B. Narasimhulu
Sivaprakasam, Prasanna
Lewis, Hal
Kish, Kevin
Khan, Javed A.
Ng, Alicia
Trainor, George L.
Cianci, Christopher
Dicker, Ira B.
Walker, Michael A.
Lin, Zeyu
Protack, Tricia
Discotto, Linda
Jenkins, Susan
Gerritz, Samuel W.
Pendri, Annapurna
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (05) : 2620 - 2637
[5] Discovery of HCV-796: A potent and orally bioavailable hepatitis-C polymerase inhibitor under clinical development
Saha, Ashis K.
Young, C.
Del Vecchio, A. M.
Bailey, T. A.
Reinhardt, J. A.
Kulkarni, B. A.
Faitg, T. H.
Feng, H.
Rippin, S. R.
Blackledge, C. W.
Rys, D. J.
Lessen, T. A.
Swestock, J.
Deng, Y.
Nitz, T. J.
Chunduru, S.
Chopra, R.
Collett, M.
Pevear, D.
Howe, A. Y. M.
O'Connell, J.
Mansour, T.
Burns, C. J.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 577 - 577
[6] Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon
Zhang, Weihe
Vadlakonda, Satish
Wu, Minwan
Chintareddy, Venkat
Vogeti, L. N.
Juarez, Luis
Muppa, Saritha
Parker, Cynthia
Kellogg-Yelder, Debra
Williams, Jason
Polach, Kevin
Chen, Xilin
Raman, Krishnan
Babu, Y. S.
Kotian, Pravin
BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 73
[7] Identification of potent, orally bioavailable nonnucleoside HCV RNA polymerase inhibitors
Dragovich, Peter S.
Brooks, Jennifer
Bartkowski, Darian M.
Blazel, Julie K.
Dao, Kimkim
Ellis, David A.
Gobbi, Alberto
Kamran, Ruhi
Kim, Sun Hee
LeBrun, Laurie A.
Li, Lian-Sheng
Murphy, Douglas E.
Nolan, Thomas G.
Norris, Daniel A.
Patel, Rupal
Ruebsam, Frank
Sergeeva, Maria V.
Shah, Amit M.
Showalter, Richard E.
Stankovic, Nebojsa
Sun, Zhongxiang
Tran, Chinh V.
Tran, Martin T.
Tsan, Mei
Webber, Stephen E.
Xiang, Alan X.
Zhao, Jingjing
Kirkovsky, Leo
Zhou, Yuefen
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
[8] Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT
Parthasarathy, Saravanan
Henry, Kenneth
Pei, Huaxing
Clayton, Josh
Rempala, Mark
Johns, Deidre
De Frutos, Oscar
Garcia, Pablo
Mateos, Carlos
Pleite, Sehila
Wang, Yong
Stout, Stephanie
Condon, Bradley
Ashok, Sheela
Lu, Zhohai
Ehlhardt, William
Raub, Tom
Lai, Mei
Geeganage, Sandaruwan
Burkholder, Timothy P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (10) : 1887 - 1891
[9] Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors
Velcicky, Juraj
Janser, Philipp
Gommermann, Nina
Brenneisen, Silke
Ilic, Slavica
Vangrevelinghe, Eric
Stiefl, Nikolaus
Boettcher, Andreas
Arnold, Christelle
Malinverni, Claire
Dawson, Janet
Murgasova, Renata
Desrayaud, Sandrine
Beltz, Karen
Hinniger, Alexandra
Dekker, Carien
Farady, Christopher J.
Mackay, Angela
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (02) : 1544 - 1562
[10] Discovery of ITX 4520: A highly potent orally bioavailable hepatitis C virus entry inhibitor
Mittapalli, Gopi Kumar
Zhao, Fang
Jackson, Andrew
Gao, Hongfeng
Lee, Haekyung
Chow, Stephine
Kaur, Maninder Pal
Natalie Nguyen
Zamboni, Robert
McKelvy, Jeffrey
Wong-Staal, Flossie
Macdonald, James E.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (15) : 4955 - 4961

← 1 2 3 4 5 →